GABRB3 and cholangiocarcinoma: We obtained in vivo evidence for deregulation of this tumor suppressive mechanism in human cholangiocarcinomas [21], where several genes involved in taurine-mediated volume regulation (GABRB3, PANK1 and LRRC8a) were repressed.